MetLife stock performance snapshot

MetLife (MET) has drawn investor attention after recent price moves, with the stock last closing at $83.46. The company reports annual revenue of $77.58b and net income of $3.43b, supported by multiple global business segments.

Recent trading has been firm, with a 1 day share price return of 3.09% and a 90 day share price return of 16.19%. The 5 year total shareholder return of 52.11% points to momentum that has built over time.

If MetLife’s move has you thinking about what else is out there, this could be a good moment to scan for other opportunities using the 21 top founder-led companies

With MetLife trading at $83.46 and indicators such as analyst targets and intrinsic value estimates suggesting potential gaps, the real question is whether this reflects a genuine undervaluation or a stock where expectations for future growth are already priced in.

Most Popular Narrative: 6.6% Undervalued

MetLife’s most followed narrative points to a fair value of $89.31, compared with the last close at $83.46. This frames the current debate around upside potential.

Strategic expansion of asset-light, fee-generating businesses (like employee benefits, asset management, and longevity reinsurance), combined with disciplined capital management, supports higher return on equity and more consistent, less capital-intensive earnings growth.

Want to see what sits underneath that view of MetLife’s future cash generation? The narrative leans heavily on steady revenue expansion, higher margins, and a different earnings mix over time. The key is how those assumptions stack together in the valuation model.

Result: Fair Value of $89.31 (UNDERVALUED)

However, investors still need to watch for pressure on investment yields and commercial mortgage loan losses, which could weaken profitability and unsettle the valuation story.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Another angle on valuation

That 6.6% gap to the $89.31 fair value rests on analyst assumptions about earnings and multiples. A different lens, using our earnings based fair ratio, paints a less generous picture, with MET’s current 15.6x P/E above both the 13.2x fair ratio and the 10.3x industry average, which suggests less margin for error if anything goes off script.

For investors weighing this, the key question is whether the higher P/E reflects durable strengths or just crowded optimism. See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Mixed signals so far, with valuation gaps, potential risks and some clear positives. For the full picture, weigh the 3 key rewards and 1 important warning sign.

Looking for more investment ideas?

If MetLife has sharpened your interest, do not stop here. Broaden your watchlist with other stock ideas that could suit different goals and risk levels.

• Target potential upside in quality opportunities by scanning for 47 high quality undervalued stocks that pair fundamentals with prices that still look reasonable.
• Strengthen your income focus by zeroing in on 10 dividend fortresses that put cash returns at the center of the investment case.
• Prioritize resilience by filtering for 65 resilient stocks with low risk scores that score well on stability so you are not relying on guesswork.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.